ScieGen Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
89 Arkay Dr, Hauppauge, New York, 11788,...Phone Number
(631) 434-2723Website
www.sciegenpharm.comRevenue
$23.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
2
1
1
About ScieGen Pharmaceuticals
ScieGen Pharmaceuticals is a fast-growing generic pharmaceutical company based in Hauppauge, New York, specializing in the development, manufacturing, marketing, and distribution of high-quality generic medicines. The company has a robust product development pipeline with over 60 Abbreviated New Drug Applications (ANDAs) filed, focusing on providing cost-effective healthcare solutions. All products are manufactured in state-of-the-art facilities in the USA, ensuring compliance with cGMP standards. ScieGen aims to enhance patient access to affordable medications while maintaining a commitment to quality and safety.Explore more
ScieGen Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ScieGen Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ScieGen Pharmaceuticals launches new products
Earning: See what the market has to say on ScieGen Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ScieGen Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ScieGen Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ScieGen Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ScieGen Pharmaceuticals
Check if ScieGen Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if ScieGen Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined ScieGen Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to ScieGen Pharmaceuticals
Compare insights from companies similar to ScieGen Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ScieGen Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ScieGen Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ScieGen Pharmaceuticals.
ScieGen Pharmaceuticals Tech Stack
A closer look at the technologies used by ScieGen Pharmaceuticals
Most Recent Scoops
Event
Events
Facilities Relocation / Expansion
ScieGen Pharmaceuticals is planning to move its offices in October 2023. The move will impact employees at their existing office located at 89 Arkay Dr, Hauppauge, NY.
Facilities Relocation / Expansion
ScieGen Pharmaceuticals is planning to move its offices in October 2021. The move will impact approximately 200 employees at their existing office located at 330 Oser Ave, Hauppauge, NY.
Facilities Relocation/Expansion
Facilities Relocation / Expansion
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ScieGen Pharmaceuticals
Sign Up For FreeTo access detailed company insights
ScieGen Pharmaceuticals is a fast-growing generic pharmaceutical company based in Hauppauge, New York, specializing in the development, manufacturing, marketing, and distribution of high-quality generic medicines. The company has a robust product development pipeline with over 60 Abbreviated New Drug Applications (ANDAs) filed, focusing on providin... Read More
